海正生材(688203) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 205,373,557.97, representing a 7.00% increase compared to CNY 191,942,300.79 in the same period last year[4] - Net profit attributable to shareholders decreased by 96.62% to CNY 233,434.57 from CNY 6,908,454.19 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 97.45% to CNY 164,498.78 from CNY 6,461,665.26 in the previous year[4] - Basic and diluted earnings per share were both CNY 0.0012, a decrease of 96.00% compared to CNY 0.03 in the same period last year[4] - Operating profit for Q1 2025 was CNY 2.38 million, down 72.05% from CNY 8.48 million in Q1 2024[18] - Net profit for Q1 2025 was CNY 0.23 million, a significant decrease of 96.63% compared to CNY 6.91 million in Q1 2024[19] Cash Flow and Liquidity - The net cash flow from operating activities improved to CNY 17,227,769.66, compared to a negative CNY 22,251,731.82 in the same period last year[4] - Operating cash flow for Q1 2025 was CNY 17.23 million, a recovery from a negative cash flow of CNY -22.25 million in Q1 2024[21] - Cash inflow from operating activities totaled CNY 202.18 million, compared to CNY 201.19 million in Q1 2024[21] - The net cash flow from financing activities was $9,129,027.79, a decrease from $13,950,455.95 in the previous period[22] - The total cash outflow from financing activities amounted to $15,520,972.21, compared to $15,059,280.55 previously[22] - The net increase in cash and cash equivalents was -$25,992,395.87, down from -$105,616,525.80 in the prior period[22] - The ending balance of cash and cash equivalents was $461,216,841.07, a decrease from $725,127,468.63 year-over-year[22] - The beginning balance of cash and cash equivalents was $487,209,236.94, compared to $830,743,994.43 previously[22] - The impact of exchange rate changes on cash and cash equivalents was $243,241.45, down from $688,075.00[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,005,226,928.81, down 2.92% from CNY 2,065,606,241.64 at the end of the previous year[5] - The company's total assets decreased from CNY 2,065,606,241.64 on December 31, 2024, to CNY 2,005,226,928.81 on March 31, 2025, a decline of approximately 2.9%[15] - Cash and cash equivalents decreased from CNY 515,730,236.94 to CNY 478,929,341.07, a reduction of about 7.1%[13] - Accounts receivable increased from CNY 53,813,085.81 to CNY 61,473,311.85, representing an increase of approximately 14.5%[14] - Inventory decreased from CNY 160,518,912.59 to CNY 123,710,781.06, a decline of about 23%[14] - Current liabilities decreased from CNY 481,453,686.46 to CNY 423,631,470.33, a reduction of approximately 12%[15] - Non-current liabilities slightly decreased from CNY 92,596,927.46 to CNY 91,807,079.53, a decline of about 0.85%[15] - Total liabilities and equity amounted to CNY 2.01 billion, reflecting a decrease from CNY 2.07 billion in the previous period[16] Research and Development - Research and development expenses totaled CNY 6,824,236.37, accounting for 3.32% of operating revenue, a decrease of 0.23 percentage points from 3.55%[5] - Research and development expenses for Q1 2025 were CNY 6.82 million, slightly up from CNY 6.81 million in Q1 2024[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,673[8] - Zhejiang Haizheng Group holds 38.76% of shares, making it the largest shareholder[10] Non-Recurring Gains and Other Information - The company recognized non-recurring gains of CNY 68,935.79 during the reporting period, after accounting for tax effects[7] - The company has no significant new product launches or technological developments mentioned in the reports[12] - There are no new strategies or market expansions indicated in the current financial reports[12]